Evidence for a novel TGF-β1 - Independent mechanism of fibronectin production in mesangial cells overexpressing glucose transporters

Diabetes

Volumn 52, Issue 2, 2003, Pages 527-535

  Weigert, Cora ^a   Brodbeck, Katrin ^a   Brosius III, Frank C ^c   Huber, Matthias ^a   Lehmann, Rainer ^a   Friess, Ulrich ^a   Facchin, Sonia ^a   Aulwurm, Steffen ^a   Häring, Hans U ^a   Schleicher, Erwin D ^a   Heilig, Charles W ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; CYTOKINE; FIBRONECTIN; GLUCOSE; GLUCOSE TRANSPORTER 1; HEXOSAMINE; ISOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN C JUN; PROTEIN KINASE C; SCLEROPROTEIN; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL TRANSPORT; CYTOKINE PRODUCTION; DIABETIC NEPHROPATHY; DNA BINDING; DOSE RESPONSE; ENZYME INHIBITION; ENZYME METABOLISM; EXTRACELLULAR MATRIX; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GLUCOSE TRANSPORT; GLUT1 GENE; HUMAN; HUMAN CELL; HYPERGLYCEMIA; INHIBITION KINETICS; MESANGIUM CELL; MOLECULAR MECHANICS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; TRANSPORT KINETICS;

ANIMALS; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBRONECTINS; GLOMERULAR MESANGIUM; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; LACTATES; MONOSACCHARIDE TRANSPORT PROTEINS; PROTO-ONCOGENE PROTEINS C-JUN; RATS; TRANSCRIPTION FACTOR AP-1; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0037312897     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.2.527     Document Type: Article

References (50)

1. Osterby R: Glomerular structural changes in type 1 (insulin-dependent) diabetes mellitus: causes, consequences, and prevention. Diabetologia 35:803-812, 1992
2. Mauer SM, Steffes MW, Ellis EN, Sutherland DF, Brown DM, Goetz FC: Structural-functional relationships in diabetic nephropathy. J Clin Invest 74:1143-1155, 1984
3. Nerlich A, Schleicher E: Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions. Am J Pathol 139:889-899, 1991
4. The Diabetes Control and Complications: Trial research group: The effects of intensive insulin treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
5. Ayo SH, Radnik RA, Garoni JA, Glass WF, Kreisberg JI: High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells. Am J Pathol 136:1339-1348, 1990
6. Fukui M, Nakamura T, Ebihara I, Shirato I, Tomino Y, Koide H: ECM gene expression and its modulation by insulin in diabetic rats. Diabetes 41: 1520-1527, 1992
7. Studer RK, Craven PA, DeRubertis FR: Role for protein kinase C in the mediation of increased fibronectin accumulation by mesangial cells grown in high-glucose medium. Diabetes 42:118-126, 1993
8. Ziyadeh FN, Sharma K, Ericksen M, Wolf G: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. J Clin Invest 93:536-542, 1994
9. Kolm V, Sauer U, Olgemöller B, Schleicher E: High glucose-induced TGF-β1 regulates mesangial production of heparan sulfate proteoglycan. Am J Physiol 270:F812-F821, 1996
10. Ayo SH, Radnik R, Garoni JA, Troyer DA, Kreisberg JI: High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell cultures. Am J Physiol 261:F571-F577, 1991
11. Mogyorosi A, Ziyadeh FN: GLUT1 and TGF-β: the link between hyperglycemia and diabetic nephropathy. Nephrol Dial Transplant 14:2827-2829, 1999
12. Heilig CW, Liu Y, England RL, Freytag SO, Gilbert JD, Heilig KO, Zhu M, Concepcion LA, Brosius III FC: D-Glucose stimulates mesangial cell GLUT1 expression and basal and IGF-1-sensitive glucose uptake in rat mesangial cells. Diabetes 46:1030-1039, 1997
13. Inold K, Haneda M, Maeda S, Koya D, Kikkawa R: TGF-β1 stimulates glucose uptake by enhancing GLUT1 expression in mesangial cells. Kidney Int 55:1704-1712, 1999
14. Quinn LA, McCumbee WD: Regulation of glucose transport by anglotensin II and glucose in cultured vascular smooth muscle cells. J Cell Physiol 177:94-102, 1998
15. D'Agord Schaan B, Lacchini S, Bertoluci MC, Irigoyen MC, Machado UF, Schmid H: Increased renal GLUT1 abundance and urinary TGF-beta 1 in streptozotocin-induced diabetic rats: implications for the development of nephropathy complicating diabetes. Horm Metab Res 33:664-669, 2001
16. Liu ZH, Chen ZH, Li Y-J, Liu D, Li LS: Phenotypic alterations of live mesangial cells in patients with diabetic nephropathy obtained from renal biopsy specimen (Abstract). J Am Soc Nephrol 10:A0669, 1999
17. Hodgkinson AD, Millward BA, Demaine AG: Polymorphisms of the glucose transporter (GLUT1) gene are associated with diabetic nephropathy. Kidney Int 59:985-989, 2001
18. Heilig CW, Conception LA, Riser BL, Freytag SO, Zhu M, Cordes P: Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype. J Clin Invest 96:1802-1814, 1995
19. Heilig CW, Kreisberg JI, Freytag S, Murakami T, Ebina Y, Guo L, Heilig K, Loberg R, Qu X, Jin Y, Henry D, Brosius FC III: Antisense GLUT-1 protects mesangial cells from glucose induction of GLUT-1 and fibronectin expression. Am J Physiol Renal Physiol 280:F657-F666, 2001
20. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA: Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci U S A 90:1814-1818, 1993
21. Iwano M, Kubo A, Nishino T, Sato H, Nishioka H, Akai Y, Kurioka H, Fujii Y, Kanauchi M, Shiiki S, Dohi K: Quantification of glomerular TGF-β1 mRNA in patients with diabetes mellitus. Kidney Int 49:1120-1126, 1996
22. Ziyadeh FN, Hoffman BB, Iglesias-De la Cruz M, Han D, Hong W, Isono M, Chen S, McGowan T, Sharma K: Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-β antibody in db/db diabetic mice. Proc Natl Acad Sci U S A 97:8015-8020, 2000
23. Koya D, Haneda M, Nakagawa H, Isshiki K, Sato H, Maeda S, Sugimoto T, Yasuda H, Kashiwagi A, Ways DK, King GL, Kikkawa R: Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB J 14:439-447, 2000
24. Kolm-Litty V, Sauer U, Nerlich A, Lehmann R, Schleicher ED: High glucose-induced transforming growth factor β1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. J Clin Invest 101:160-169, 1998
25. Goldberg HJ, Scholey J, Fantus IG: Glucosamine activates the plasminogen activator inhibitor 1 gene promoter through Sp1 DNA binding sites in glomerular mesangial cells. Diabetes 49:863-871, 2000
26. Haneda M, Araki S, Togawa M, Sugimoto T, Isono M, Kikkawa R: Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes 46:847-853, 1997
27. Isono M, Cruz MC, Chen S, Hong SW, Ziyadeh FN: Extracellular signal-regulated kinase mediates stimulation of TGF-β1 and matrix by high glucose in mesangial cells. J Am Soc Nephrol 11:2222-2230, 2000
28. Igarashi M, Wakasaki H, Takahara N, Ishii H, Yang YJ, Yamauchi T, Kuboki K, Meier M, Rhodes CJ, King GL: Glucose or diabetes activate p38 mitogen-activated protein kinase via different pathways. J Clin Invest 103:185-195, 1999
29. Weigert C, Sauer U, Brodbeck K, Pfeiffer A, Haering HU, Schleicher ED: AP-1 proteins mediate hyperglycemia-induced activation of the human TGF-β1 promoter in mesangial cells. J Am Soc Nephrol 11:2007-2016, 2000
30. Nishikara T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787-790, 2000
31. Du XL, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh F, Wu J, Browulee M: Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A 97:12222-12226, 2000
32. Iglesias-De La Cruz MC, Ruiz-Torres P, Alcami J, Diez-Marques L, Ortega-Velazquez R, Chen S, Rodriguez-Puyol M, Ziyadeh FN, Rodriguez-Puyol D: Hydrogen peroxide increases extracellular matrix mRNA through TGF-beta in human mesangial cells. Kidney Int 59:87-95, 2001
33. Hoffman BB, Sharma K, Zhu Y, Ziyadeh FN: Transcriptional activation of transforming growth factor-β1 in mesangial cell culture by high glucose concentration. Kidney Int 54:1107-1116, 1998
34. Kreisberg JI, Garoni JA, Radnik R, Ayo SH: High glucose and TGF-β1 stimulate fibronectin gene expression through a cAMP response element. Kidney Int 46:1019-1024, 1994
35. Hocevar BA, Brown TL, Howe PH: TGF-β induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J 18:1345-1356, 1999
36. Wilmer WA, Cosio FG: DNA binding of activator protein-1 is increased in human mesangial cells cultured in high glucose concentrations. Kidney Int 53:1172-1181, 1998
37. Kreisberg JI, Radnik RA, Ayo SH, Garoni J, Saikumar P: High glucose elevates c-fos and c-jun transcripts and proteins in mesangial cell cultures. Kidney Int 46:105-112, 1994
38. Kim S-J, Angel P, Lafyatis R, Hattori K, Kim KY, Sporn MB, Karin M, Roberts AB: Autoinduction of transforming growth factor β1 is mediated by the AP-1 complex. Mol Cell Biol 10:1492-1497, 1990
39. Nerlich AG, Sauer U, Kolm-Litty V, Wagner E, Koch M, Schleicher ED: Expression of glutamine:fructose-6-phosphate amidotransferase in human tissues: evidence for high variability and distinct regulation in diabetes. Diabetes 47:170-178, 1998
40. Ceol M, Gambaro G, Sauer U, Baggio B, Anglani F, Forino M, Facchin S, Bordin L, Weigert C, Nerlich A, Schleicher ED: Glycosaminoglycan therapy prevents TGF-β1 overexpression and pathologic changes in renal tissue of long-term diabetic rats. J Am Soc Nephrol 11:2324-2336, 2000
41. Netzker R, Weigert C, Brand K: Role of the stimulatory proteins Sp1 and Sp3 in the regulation of transcription of the rat pyruvate kinase M gene. Eur J Biochem 245:174-181, 1997
42. Lehmann R, Huber M, Beck A, Schindera T, Rinkler T, Houdali B, Weigert C, Haring HU, Voelter W, Schleicher ED: Simultaneous, quantitative analysis of UDP-N-acetylglucosamine, UDP-N-acetylgalactosamine, UDP-glucose and UDP-galactose in human peripheral blood cells, muscle biopsies and cultured mesangial cells by capillary zone electrophoresis. Electrophoresis 21:3010-3015, 2000
43. Tamura K, Nyui N, Tamura N, Fujita T, Kihara M, Toya Y, Takasaki I, Takagi N, Ishii M, Oda K, Masatsugu H, Umemura S: Mechanism of angiotensin II-mediated regulation of fibronectin gene in rat vascular smooth muscle cells. J Biol Chem 41:26487-26496, 1998
44. Ahmad M, Theofanidis P, Medford RM: Role of the activating protein-1 in the regulation of the vascular cell adhesion molecule-1 gene expression by tumor necrosis factor-α. J Biol Chem 273:4616-4621, 1998
45. Greenwel P, Inagaki Y, Hu W, Walsh M, Ramirez F: Sp1 is required for the early response of alpha2(I) collagen to transforming growth factor-beta1. J Biol Chem 272:19738-19745, 1997
46. Henry DN, Busik JV, Brosius III FC, Heilig CW: Glucose transporters control gene expression of aldose reductase, PKCa, and GLUT1 in mesangial cells in vitro. Am J Physiol 277:F97-F104, 1999
47. Alpert E, Gruzman A, Totary H, Kaiser N, Reich R, Sasson S: A natural protective mechanism against hyperglycaemia in vascular endothelial and smooth-muscle cells: role of glucose and 12-hydroxyeicosatetraenoic acid. Biochem J 362:413-422, 2002
48. Burstein DE, Reder I, Weiser K, Tong T, Pritsker A, Haber RS: GLUT1 glucose transporter: a highly sensitive marker of malignancy in body cavity effusions. Mol Pathol 11:392-396, 1998
49. Zhang JZ, Behrooz A, Ismail-Beigl F: Regulation of glucose transport by hypoxia. Am J Kidney Dis 34:189-202, 1999
50. Meyer C, Stumvoll M, Nadkarni V, Dostou J, Mitrakou A, Gerich J: Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus. J Clin Invest 102:619-624, 1998